Alzheimer's Disease Trial, Not Yet Recruiting NCT05796037 Sponsor: Target PharmaSolutions, Inc. Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Not Yet Recruiting

NCT05796037
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults who have been diagnosed with Alzheimer's disease, related dementias, mild cognitive impairment, Parkinson's disease, or multiple sclerosis, as recorded in their electronic health record.
  • Adults who are being diagnosed and treated for one of the conditions listed above and are invited to take part.
  • People who are able to sign a written consent form, or who have a legally authorised representative who can sign on their behalf.
  • Care partners (such as family members or carers) may be invited to take part in surveys and would provide their own consent to do so.
  • Adults who are 60 years of age or older at the time of joining the trial.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have passed away.
  • People who have been removed from the trial at the request of the trial sponsor or the trial site.
  • People who have had no visits or interactions recorded in the electronic health record system for more than 3 years.
  • People in the Engaged Cohort group who have expressed a wish to stop completing the health surveys.
  • Care partners in the Engaged Cohort group who have expressed a wish to stop completing the health surveys.
  • People in the Engaged Cohort group who did not complete the health surveys within 24 weeks of first being invited.
  • People in the Engaged Cohort group who have had a gap of more than 24 months in completing surveys after finishing the initial set.
  • People in the Engaged Cohort group who do not meet the disease-related criteria that apply to the main Disease Cohort group (confirm with trial site).
  • People listed under the Age Cohort group who have passed away.
  • People listed under the Age Cohort group who have been removed at the request of the sponsor or trial site.
  • People listed under the Age Cohort group who have had no electronic health record interactions for more than 3 years.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 18 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Target PharmaSolutions, Inc.
Registry
ClinicalTrials.gov
Start date
31 March 2025
Est. completion
31 December 2038

Primary endpoints

To characterize the natural history of disease in patients living with chronic neurological diseases including ADRD, MCI, PD, or MS; To assess safety and effectiveness of disease treatments and treatments for complications of patients receiving various treatments, effectiveness of treatment, and medical events that develop while receiving treatment for ADRD, MCI, PD, or MS.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov